口服免疫耐受性机制的研究进展由乳清蛋白诱导

Mao Lin1, Qianqian Zhang1, Yanjun Cong1

  • 1College of Food and Health, Beijing Technology and Business University, Beijing 100048, China.

Nutrients
|May 14, 2025
PubMed
概括

口服免疫耐受性 (OIT) 有效地治疗儿童牛奶过敏 (CMA). 本综述探讨了涉及肠道免疫系统,调节性T细胞和微生物群的OIT机制,重点关注低过敏配方的乳清蛋白.